Loading...

Pre-revenue Startup Valuation India

Quick answer: Pre-revenue startups are valued using methods that do not depend on current earnings — DCF on projected cash flows, comparable transactions, and venture-capital, Berkus or scorecard methods. Indian law accepts these for tax and FEMA purposes when the valuation is performed by a credentialed valuer with documented assumptions.

Looking for expert pre-revenue startup valuation india? Virtual Auditor provides practitioner-grade startup valuation services in India, led by CA V. Viswanathan — IBBI Registered Valuer (IBBI/RV/03/2019/12333) | Fellow Chartered Accountant (FCA) | Associate Company Secretary (ACS) | Certified Fraud Examiner (CFE). We combine deep regulatory expertise with hands-on execution to deliver results within your timeline.

What We Deliver

Valuation report compliant with Rule 11UA / Section 56(2)(viib) / FEMA 20(R) — as applicable to your funding round. DCF model with detailed assumptions, revenue projections, and discount rate justification. Monte Carlo simulation output with probability-weighted fair value range. Cap table impact analysis showing pre-money, post-money, and dilution scenarios. Investor-ready executive summary with methodology explanation.

Last reviewed: July 2026 by CA V. Viswanathan (FCA, ACS, CFE, IBBI Registered Valuer)

The Core Problem: Valuing a Company Before It Sells Anything

A pre-revenue startup has no sales history, often no product in market, and cash flows that exist only in a spreadsheet. The classic tools — earnings multiples, historical DCF, comparable transactions — have nothing to bite on. Yet a number is still needed: to price a seed round, to set founder-versus-investor equity splits, and increasingly to satisfy regulators who do not accept "it's too early to value". The solution is a family of purpose-built qualitative and semi-quantitative methods that convert the things a pre-revenue company does have — a team, a market, a prototype, early signals — into a defensible valuation range. We triangulate across several rather than trusting any single one.

The Four Workhorse Methods

MethodHow it worksBest for
BerkusAssigns a monetary value (capped) to each of five risk-reduction milestones: sound idea, prototype, quality team, strategic relationships, product rollout/salesIdea and prototype stage
Scorecard (Bill Payne)Takes an average regional seed valuation and adjusts it up or down against weighted factors (team, market size, product, competition, etc.)Companies with comparable local deals
Risk-Factor SummationStarts from a base value and adds/subtracts fixed increments across ~12 risk categories (management, funding, competition, technology, legal, etc.)Cross-checking Berkus/Scorecard
VC MethodEstimates exit value, divides by target return multiple to get post-money, subtracts investment for pre-moneyInvestor-lens pricing of the round

Worked Logic — the VC Method in Practice

The VC method is worth walking through because it exposes the arithmetic investors actually use:

  1. Estimate the exit: suppose the company could plausibly be sold for ₹300 crore in year six, based on a target revenue and a sector exit multiple.
  2. Apply the target return: a seed investor might require a 20x return to compensate for portfolio failure. Post-money valuation today = ₹300 crore ÷ 20 = ₹15 crore.
  3. Back out pre-money: if the investor puts in ₹3 crore, pre-money = ₹15 crore − ₹3 crore = ₹12 crore.
  4. Adjust for future dilution: because later rounds will dilute the seed investor, the required ownership is grossed up, pulling the effective pre-money down further.

The Berkus and Scorecard methods, by contrast, build value up from qualitative milestones, and the Risk-Factor Summation stress-tests the result against a checklist of what could go wrong. When all three or four cluster in a band, the range is defensible; when they diverge, that divergence itself is diagnostic information for the founder.

When Tax and Regulation Still Force a DCF or NAV

Here is the tension founders hit: the qualitative methods above are how the market prices a seed round, but they are not what Indian law recognises for a formal report. When you issue shares at a premium, the valuation for tax and FEMA purposes must run through recognised methods:

  • Rule 11UA: permits a Net Asset Value (NAV) computation or a Discounted Cash Flow — not Berkus or Scorecard. For a pre-revenue company this means a projection-driven DCF, however uncertain, or an NAV that will look very low against the round price.
  • The angel-tax history: the gap between a high market-negotiated price and a low NAV is exactly what Section 56(2)(viib) once taxed. That "angel tax" has been abolished for shares issued on or after 1 April 2024, but legacy assessments for earlier years continue, and defending them turns on the quality of the DCF filed at the time.
  • FEMA: foreign angel money requires a floor price certified under an internationally accepted methodology — again DCF, not a scorecard.

The reconciliation founders miss: your investor uses Berkus to agree ₹12 crore; your statutory report must independently justify that ₹12 crore under DCF or NAV. We build both sides so the round price and the filed valuation tell a consistent story rather than contradicting each other in a later assessment.

Our Pre-Revenue Engagement and Fees

We deliver a multi-method valuation memo (Berkus, Scorecard, Risk-Factor Summation and VC method) to anchor the founder's negotiation, and where shares are being issued, the matching statutory DCF/NAV report for tax and FEMA — reconciled to the round.

ServiceFee (from)
Multi-method pre-revenue valuation memo₹20,000
Statutory DCF/NAV report for a seed issue (Rule 11UA)₹25,000
Combined negotiation memo + statutory report₹38,000
FEMA floor-price certificate for foreign angels₹25,000

Why Choose Virtual Auditor

We specialise in startup valuations at every stage — pre-revenue, seed, Series A through Series D, and exits. Our 18-method valuation engine handles the unique challenges of early-stage companies: negative cash flows, high growth uncertainty, complex capital structures (SAFEs, convertible notes, CCPS). Led by IBBI Registered Valuer CA V. Viswanathan (IBBI/RV/03/2019/12333) with FCA, ACS, and CFE credentials.

With physical offices in Chennai (Spencer Plaza), Bangalore (MG Road), and Mumbai (Goregaon West), we offer both in-person and remote engagement models.

Pre-revenue and early-stage companies present unique challenges — negative cash flows, hockey-stick projections, and complex capital structures with SAFEs, convertible notes, and CCPS with multiple liquidation preferences. Our approach uses probability-weighted scenario analysis, option pricing for complex instruments, and market-calibrated discount rates. We have valued startups from pre-seed through Series D across SaaS, fintech, healthtech, D2C, and deeptech verticals.

Our Process

Step 1: Initial consultation — funding stage, investor requirements, regulatory framework. Step 2: Cap table review and financial projection analysis. Step 3: Multi-method valuation — DCF, comparable companies, recent transactions, option pricing. Step 4: Draft report review with founders. Step 5: Final report delivery with regulatory compliance certificate.

We understand investor timelines. Our startup valuation reports are structured for investor readability — executive summary first, methodology section, detailed assumptions, and sensitivity analysis. We also prepare cap table impact summaries showing dilution scenarios that founders can share directly with their investors and board.

Get Started Today

Ready to engage Virtual Auditor for pre-revenue startup valuation india? Contact us for a free initial consultation:

Call/WhatsApp: +91 99622 60333

Email: support@virtualauditor.in

Offices: Chennai | Bangalore | Mumbai

No obligation. We will assess your requirements and provide a clear scope, timeline, and fixed-fee quote within 24 hours.

Strategic Business & Compliance Insights

Frequently Asked Questions

How do you value a startup with no revenue?
Through purpose-built methods that convert non-financial signals into value: the Berkus method assigns capped amounts to milestones like a working prototype and a quality team; the Scorecard method adjusts an average regional seed valuation against weighted factors; Risk-Factor Summation adds and subtracts increments across risk categories; and the VC method works backward from a projected exit and target return. We triangulate across several because no single method is reliable for a company that has not yet sold anything.
What is the Berkus method?
The Berkus method values a pre-revenue startup by assigning a monetary value — each capped, historically around half a million dollars but scaled to the local market — to five risk-reduction elements: a sound basic idea, a working prototype, a quality management team, strategic relationships, and product rollout or early sales. Summing them gives a pre-money valuation. It deliberately caps values to keep early-stage numbers grounded and is best suited to idea and prototype-stage companies before traction data exists.
What is the VC method of valuation?
The VC method prices a round from an investor's perspective. You estimate a plausible exit value in, say, five to six years, divide it by the return multiple the investor needs (often 10-30x at seed to cover portfolio losses) to get today's post-money valuation, then subtract the investment to derive pre-money. You then gross up for expected dilution from future rounds. It makes explicit the exit-and-return logic investors actually use, which is why founders benefit from modelling it before negotiating.
If we have no revenue, why does our tax valuation use DCF?
Because Indian law recognises only certain methods for a formal share-issue valuation. Rule 11UA permits Net Asset Value or Discounted Cash Flow — not Berkus or Scorecard, which are negotiation tools, not statutory methods. So even a pre-revenue company issuing shares at a premium needs a projection-driven DCF or an NAV computation for tax, and an internationally accepted methodology (again usually DCF) for FEMA. The market number and the statutory number must then be reconciled.
Does angel tax still apply to pre-revenue startups?
Section 56(2)(viib) — the so-called angel tax on share premium above fair value — has been abolished for shares issued on or after 1 April 2024. However, assessments for earlier years continue to run, and many pre-revenue companies that raised before that date are still defending the gap between their round price and their computed fair value. Defending those legacy assessments depends heavily on the quality and contemporaneity of the DCF that supported the original issue.
Which pre-revenue method gives the most accurate valuation?
None is accurate in isolation — that is why we use several. The Berkus and Scorecard methods build value from qualitative milestones and local comparables; Risk-Factor Summation cross-checks against a risk checklist; the VC method anchors to exit economics. When the methods cluster within a band, that band is defensible. When they diverge, the divergence tells the founder where the uncertainty lies. Treating any single number as precise is the classic pre-revenue valuation mistake.
What documents do you need to value a pre-revenue startup?
A pitch deck, the founding team's backgrounds, any prototype or product evidence, the target market sizing, the cap table, the proposed round size and instrument, and whatever early signals exist — waitlist numbers, letters of intent, pilot agreements. For the statutory DCF we also need a financial projection, however preliminary. Much of the value we add early is helping structure those projections so they are credible for both investor negotiation and the tax and FEMA reports that follow.